Login / Signup

The long-term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis-52 week results from the Dutch BioDay Registry.

Angelique N VoorbergGeertruida L E RomeijnMarjolein de Bruin-WellerMarie-Louise A Schuttelaar
Published in: Contact dermatitis (2022)
The results from this study hold promise for dupilumab to be a suitable treatment option for isolated CHE.
Keyphrases
  • atopic dermatitis
  • high intensity
  • early onset
  • randomized controlled trial
  • drug induced
  • replacement therapy